LXRX
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
Monday, May 4, 2026 BiopharmaWatch Research 1 min read Key Takeaway: Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
Price reaction · baseline $1.63 (2026-05-01 close) · 1 other LXRX headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus
Full Press Release Details
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital.